Skip to content

Survival of the Insignia Stem in Total Hip Arthroplasty

Mid-term Survival of the Insignia Stem in Primary Total Hip Arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05313321
Enrollment
100
Registered
2022-04-06
Start date
2022-03-17
Completion date
2028-03-01
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Total Hip Arthroplasty

Keywords

Primary Total Hip Arthroplasty, Insignia™ Hip Stem, Radiographic review

Brief summary

The investigators primary objective of this study is to evaluate radiographic fit and fill of the Insignia stem and identify risk factors for aseptic failure. The investigators hypotheses being tested is: the newly designed Insignia stem demonstrates acceptable radiographic fit and fill by reviewing radiolucent lines \<2mm.

Detailed description

Total hip arthroplasty is one of the most functionally restorative procedures in modern medicine. Since its introduction in the mid twentieth century significant advancements in implant materials have occurred. There is debate on the design of the femoral stem in total hip arthroplasty. The use of uncemented, Hydroxyapatite (HA)-coated femoral stems have been shown to be reliable and are commonly used. One such implant is the Insignia™ Hip Stem (Stryker, Kalamazoo, MI, USA). The Insignia™ Hip Stem is a collared stem that features a plasma-sprayed Hydroxyapatite (HA) coating over plasma-sprayed titanium in the proximal region and a plasma-sprayed HA coating over grit blast in the distal region and collar underside. Unfortunately, with it's novelty comes a lack of clinical follow-up and evaluation. As such, the investigators purpose of this study is to evaluate the early radiographic of the Insignia™ Hip Stem.

Interventions

DEVICEPrimary total hip arthroplasty receiving the Insignia Stem

Patients receiving the Insignia Stem and associated Stryker Acetabular Component for total hip arthroplasty

Sponsors

University of Utah
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients age ≥18 * Patients planning on undergoing primary total hip arthroplasty that will likely receive the Insignia stem and associated Stryker Acetabular Component. * Preoperative diagnosis of osteoarthritis * Patients willing and able to comply with follow-up requirements * Patients willing to sign an IRB approved consent and authorization document

Exclusion criteria

* Patients with inflammatory or pyogenic arthritis * Body Mass Index (BMI)\>40 * Bone stock that is inadequate for support or fixation of the prosthesis

Design outcomes

Primary

MeasureTime frameDescription
Radiographs reviewPre-operativeReviewing radiographic radiolucent lines \<2mm

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLucas Anderson, M.D.

University of Utah Orthopaedics

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026